ArticleTobacco control2015
Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada.
Article in Tobacco control, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health technology assessment (Winchester, England) · 2023Pooled it
- Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019Pooled it
- Evaluation of a Community-based Quality Improvement Smoking Cessation Program Using the Ottawa Model During COVID-19.CJC open · 2026Article
- Cost-effectiveness of point of care smoking cessation interventions in oncology clinics.British journal of cancer · 2024Article
- Specialist cancer hospital-based smoking cessation service provision in Ireland.Irish journal of medical science · 2024Article
- Hospital length of stay and readmission after elective surgery: a comparison of current and former smokers with non-smokers.BMC health services research · 2024Article
- Estimating the Cost of Delivering Tobacco Cessation Intervention Package at Noncommunicable Disease Clinics in Two Districts of North India.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Clinical practice guideline: evidence, recommendations and algorithm for the preoperative optimization of anemia, hyperglycemia and smoking.Canadian journal of surgery. Journal canadien de chirurgie · 2021Review
- Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD.Applied health economics and health policy · 2021Article
- Cost-effectiveness of a nurse-delivered, inpatient smoking cessation intervention.Translational behavioral medicine · 2020Observational
- Article
- Development of interventions for an intelligent and individualized mobile health care system to promote healthy diet and physical activity: using an intervention mapping framework.BMC public health · 2019Article
- Implementing smoking cessation within cancer treatment centres and potential economic impacts.Translational lung cancer research · 2019Article
- Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 1-Year Postdischarge Health Care Costs.Medical care · 2018Article
- Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.Addiction (Abingdon, England) · 2018Article
- Smoking among hospitalized patients: A multi-hospital cross-sectional study of a widely neglected problem.Tobacco induced diseases · 2018Article
- Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes.Tobacco control · 2017Article
- Article
- Managing smoking cessation.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCigarette smoking causes many chronic diseases that are costly and result in frequent hospitalisation. Hospital-initiated smoking cessation interventions increase the likelihood that patients will become smoke-free. We modelled the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes in-hospital counselling, pharmacotherapy and posthospital follow-up, compared to usual care among smokers hospitalised with acute myocardial infarction (AMI), unstable angina (UA), heart failure (HF), and chronic obstructive pulmonary disease (COPD).
methodsWe completed a cost-effectiveness analysis based on a decision-analytic model to assess smokers hospitalised in Ontario, Canada for AMI, UA, HF, and COPD, their risk of continuing to smoke and the effects of quitting on re-hospitalisation and mortality over a 1-year period. We calculated short-term and long-term cost-effectiveness ratios. Our primary outcome was 1-year cost per quality-adjusted life year (QALY) gained.
resultsFrom the hospital payer's perspective, delivery of the OMSC can be considered cost effective with 1-year cost per QALY gained of $C1386, and lifetime cost per QALY gained of $C68. In the first year, we calculated that provision of the OMSC to 15 326 smokers would generate 4689 quitters, and would prevent 116 rehospitalisations, 923 hospital days, and 119 deaths. Results were robust within numerous sensitivity analyses. DISCUSSION: The OMSC appears to be cost-effective from the hospital payer perspective. Important consideration is the relatively low intervention cost compared to the reduction in costs related to readmissions for illnesses associated with continued smoking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.